Targeting Bone Morphogenetic Protein Receptor 2 Sensitizes Lung Cancer Cells to TRAIL by Increasing Cytosolic Smac/DIABLO and the Downregulation of X-linked Inhibitor of Apoptosis Protein

Overview

Journal Cell Commun Signal

Publisher Biomed Central

Specialties Biochemistry
Cell Biology

Date 2019 Nov 21

PMID 31744505

Citations 6

Authors

Rachel NeMoyer

Arindam Mondal

Mehul Vora

Elaine Langenfeld

Danea Glover

Michael Scott

Lauren Lairson

Christopher Rongo

David J Augeri

Youyi Peng

Salma K Jabbour

John Langenfeld

Affiliations

Soon will be listed here.

Citing Articles

BMP receptor 2 inhibition regulates mitochondrial bioenergetics to induce synergistic cell death with BCL-2 inhibitors in leukemia and NSLC cells.

Toussaint A, Singh M, Wang G, Driscoll M, Bhatt V, Ndong J Res Sq. 2024; .

PMID: 39315260 PMC: 11419183. DOI: 10.21203/rs.3.rs-5065904/v1.

Docking for EP4R antagonists active against inflammatory pain.

Gahbauer S, DeLeon C, Braz J, Craik V, Kang H, Wan X Nat Commun. 2023; 14(1):8067.

PMID: 38057319 PMC: 10700596. DOI: 10.1038/s41467-023-43506-6.

Ym155 localizes to the mitochondria leading to mitochondria dysfunction and activation of AMPK that inhibits BMP signaling in lung cancer cells.

Mondal A, Jia D, Bhatt V, Akel M, Roberge J, Guo J Sci Rep. 2022; 12(1):13135.

PMID: 35908087 PMC: 9338953. DOI: 10.1038/s41598-022-17446-y.

Bone morphogenetic protein signaling regulation of AMPK and PI3K in lung cancer cells and C. elegans.

Vora M, Mondal A, Jia D, Gaddipati P, Akel M, Gilleran J Cell Biosci. 2022; 12(1):76.

PMID: 35641992 PMC: 9153151. DOI: 10.1186/s13578-022-00817-3.

Bone morphogenetic protein receptor inhibitors suppress the growth of glioblastoma cells.

Kaye J, Mondal A, Foty R, Jia D, Langenfeld J Mol Cell Biochem. 2022; 477(5):1583-1595.

PMID: 35192123 PMC: 8989651. DOI: 10.1007/s11010-022-04383-7.

References

Fu J, Jin Y, Arend L . Smac3, a novel Smac/DIABLO splicing variant, attenuates the stability and apoptosis-inhibiting activity of X-linked inhibitor of apoptosis protein. J Biol Chem. 2003; 278(52):52660-72. DOI: 10.1074/jbc.M308036200. View

Nguyen A, Scott M, Dry S, James A . Roles of bone morphogenetic protein signaling in osteosarcoma. Int Orthop. 2014; 38(11):2313-22. DOI: 10.1007/s00264-014-2512-x. View

Langenfeld E, Hong C, Lanke G, Langenfeld J . Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines. PLoS One. 2013; 8(4):e61256. PMC: 3625205. DOI: 10.1371/journal.pone.0061256. View

Omori E, Matsumoto K, Zhu S, Smart R, Ninomiya-Tsuji J . Ablation of TAK1 upregulates reactive oxygen species and selectively kills tumor cells. Cancer Res. 2010; 70(21):8417-25. PMC: 2970664. DOI: 10.1158/0008-5472.CAN-10-1227. View

Gillissen B, Richter A, Overkamp T, Essmann F, Hemmati P, Preissner R . Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode. Cell Death Dis. 2013; 4:e643. PMC: 3674381. DOI: 10.1038/cddis.2013.67. View

Ye L, Mason M, Jiang W . Bone morphogenetic protein and bone metastasis, implication and therapeutic potential. Front Biosci (Landmark Ed). 2011; 16(3):865-97. DOI: 10.2741/3725. View

Attisano L, Wrana J . Signal transduction by the TGF-beta superfamily. Science. 2002; 296(5573):1646-7. DOI: 10.1126/science.1071809. View

Mihaly S, Ninomiya-Tsuji J, Morioka S . TAK1 control of cell death. Cell Death Differ. 2014; 21(11):1667-76. PMC: 4211365. DOI: 10.1038/cdd.2014.123. View

Nickel J, Sebald W, Groppe J, Mueller T . Intricacies of BMP receptor assembly. Cytokine Growth Factor Rev. 2009; 20(5-6):367-77. DOI: 10.1016/j.cytogfr.2009.10.022. View

10.

Yamaguchi K, NAGAI S, Ninomiya-Tsuji J, Nishita M, Tamai K, Irie K . XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J. 1999; 18(1):179-87. PMC: 1171113. DOI: 10.1093/emboj/18.1.179. View

11.

Augeri D, Langenfeld E, Castle M, Gilleran J, Langenfeld J . Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death. Mol Cancer. 2016; 15:27. PMC: 4822253. DOI: 10.1186/s12943-016-0511-9. View

12.

Zon L, Peterson R . In vivo drug discovery in the zebrafish. Nat Rev Drug Discov. 2005; 4(1):35-44. DOI: 10.1038/nrd1606. View

13.

Clement J, Raida M, Sanger J, Bicknell R, Liu J, Naumann A . Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. Int J Oncol. 2005; 27(2):401-7. View

14.

Leverkus M, Sprick M, Wachter T, Mengling T, Baumann B, Serfling E . Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation. Mol Cell Biol. 2003; 23(3):777-90. PMC: 140698. DOI: 10.1128/MCB.23.3.777-790.2003. View

15.

Taniguchi M, Ogiso H, Takeuchi T, Kitatani K, Umehara H, Okazaki T . Lysosomal ceramide generated by acid sphingomyelinase triggers cytosolic cathepsin B-mediated degradation of X-linked inhibitor of apoptosis protein in natural killer/T lymphoma cell apoptosis. Cell Death Dis. 2015; 6:e1717. PMC: 4650549. DOI: 10.1038/cddis.2015.82. View

16.

Singh A, Sweeney M, Yu M, Burger A, Greninger P, Benes C . TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers. Cell. 2012; 148(4):639-50. PMC: 3291475. DOI: 10.1016/j.cell.2011.12.033. View

17.

Jiao G, Guo W, Ren T, Lu Q, Sun Y, Liang W . BMPR2 inhibition induced apoptosis and autophagy via destabilization of XIAP in human chondrosarcoma cells. Cell Death Dis. 2014; 5:e1571. PMC: 4649848. DOI: 10.1038/cddis.2014.540. View

18.

Morioka S, Omori E, Kajino T, Kajino-Sakamoto R, Matsumoto K, Ninomiya-Tsuji J . TAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP. Oncogene. 2009; 28(23):2257-65. PMC: 2796077. DOI: 10.1038/onc.2009.110. View

19.

Roberts A, Gumienny T, Gleason R, Wang H, Padgett R . Regulation of genes affecting body size and innate immunity by the DBL-1/BMP-like pathway in Caenorhabditis elegans. BMC Dev Biol. 2010; 10:61. PMC: 2894779. DOI: 10.1186/1471-213X-10-61. View

20.

Langenfeld E, Calvano S, Abou-Nukta F, Lowry S, Amenta P, Langenfeld J . The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis. 2003; 24(9):1445-54. DOI: 10.1093/carcin/bgg100. View